Manufacturability and the Winners in Advanced Therapies - Quiz - MDSpire

Manufacturability and the Winners in Advanced Therapies

Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.

  • By

  • Stephanie Vine

  • January 13, 2026

  • 8 min

Share

Original Source(s)

Manufacturability and the Winners in Advanced Therapies

  • by Stephanie Vine

  • January 13, 2026

Related Content

ZNF25 as an immunotherapy target: pan-cancer biomarker potential and mechanistic exploration in glioma

Intrathecal nivolumab in metastatic solid tumors with leptomeningeal disease: dose escalation part of the multicenter IT-PD1/NOA-26 phase 1 trial

Incidence and Survival of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms in the Contemporary Era